POLY(ACRYLIC ACID-CO-2-ETHYLHEXYL ACRYLATE-CO-METHYL METHACRYLATE-CO-STYRENE)
General Information
Mainterm | POLY(ACRYLIC ACID-CO-2-ETHYLHEXYL ACRYLATE-CO-METHYL METHACRYLATE-CO-STYRENE) |
CAS Reg.No.(or other ID) | 27306-43-0 |
Regnum |
175.105 175.320 176.170 176.180 177.1010 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 168685 |
IUPAC Name | 2-ethylhexyl prop-2-enoate;methyl 2-methylprop-2-enoate;prop-2-enoic acid;styrene |
InChI | InChI=1S/C11H20O2.C8H8.C5H8O2.C3H4O2/c1-4-7-8-10(5-2)9-13-11(12)6-3;1-2-8-6-4-3-5-7-8;1-4(2)5(6)7-3;1-2-3(4)5/h6,10H,3-5,7-9H2,1-2H3;2-7H,1H2;1H2,2-3H3;2H,1H2,(H,4,5) |
InChI Key | HZPAOIXWRARKJJ-UHFFFAOYSA-N |
Canonical SMILES | CCCCC(CC)COC(=O)C=C.CC(=C)C(=O)OC.C=CC1=CC=CC=C1.C=CC(=O)O |
Molecular Formula | C27H40O6 |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 460.611 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 12 |
Complexity | 370.0 |
CACTVS Substructure Key Fingerprint | A A A D c f B 4 O A A A A A A A A A A A A A A A A A A A A A A A A A A w A A A A A A A A A A A B A A A A G g A A C A A A D Q C g m A I y C I A A B g C I A i D S C A A C A A A g A A A I i A E A A M g I J C K A M R C C I A A k g A A I u I e A w A A O A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 89.9 |
Monoisotopic Mass | 460.282 |
Exact Mass | 460.282 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 33 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 4 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.7438 |
Human Intestinal Absorption | HIA+ | 0.8870 |
Caco-2 Permeability | Caco2+ | 0.6615 |
P-glycoprotein Substrate | Substrate | 0.5961 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.6618 |
Inhibitor | 0.6898 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8213 |
Distribution | ||
Subcellular localization | Mitochondria | 0.7744 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8795 |
CYP450 2D6 Substrate | Non-substrate | 0.8827 |
CYP450 3A4 Substrate | Substrate | 0.5114 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7261 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.7191 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8768 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.6921 |
CYP450 3A4 Inhibitor | Inhibitor | 0.5731 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7777 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8850 |
Non-inhibitor | 0.8434 | |
AMES Toxicity | Non AMES toxic | 0.8232 |
Carcinogens | Non-carcinogens | 0.7917 |
Fish Toxicity | High FHMT | 0.9976 |
Tetrahymena Pyriformis Toxicity | High TPT | 1.0000 |
Honey Bee Toxicity | High HBT | 0.7631 |
Biodegradation | Ready biodegradable | 0.9165 |
Acute Oral Toxicity | III | 0.7234 |
Carcinogenicity (Three-class) | Non-required | 0.6838 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -4.9188 | LogS |
Caco-2 Permeability | 1.0166 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.7328 | LD50, mol/kg |
Fish Toxicity | 0.3551 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 2.8410 | pIGC50, ug/L |
From admetSAR